9966 — Alphamab Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapHigh Flyer

Annual balance sheet for Alphamab Oncology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,064	1,985	1,350	1,407	1,571
Net Total Accounts Receivable
Net Total Receivables	84.8	67.5	79.5	72.5	58.1
Total Inventory
Total Other Current Assets
Total Current Assets	2,199	2,117	1,495	1,559	1,711
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	406	545	621	578	529
Long Term Notes Receivable
Total Assets	2,640	2,705	2,118	2,137	2,242
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	330	637	385	267	254
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	366	835	560	465	410
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2,273	1,870	1,558	1,672	1,832
Total Liabilities & Shareholders' Equity	2,640	2,705	2,118	2,137	2,242
Total Common Shares Outstanding